3 Reasons Why Growth Investors Shouldn't Overlook Merit Medical (MMSI)
Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.
Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?
MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.
Merit Medical Systems, Inc. (MMSI) Hits Fresh High: Is There Still Room to Run?
Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is Merit Medical (MMSI) a Solid Growth Stock? 3 Reasons to Think "Yes"
Merit Medical (MMSI) possesses solid growth attributes, which could help it handily outperform the market.
Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
MMSI's Stock Declines Despite Q3 Earnings Beat, Higher Gross Margin
Merit Medical benefits from revenue growth in both segments and all its product categories within its Cardiovascular unit in the third quarter.
Merit Medical Systems, Inc. (MMSI) Q3 2024 Earnings Call Transcript
Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd - Chief Legal Officer & Corporate Secretary Joe Wright - President Raul Parra - Chief Financial Officer Conference Call Participants John Young - Canaccord Jayson Bedford - Raymond James Jason Bednar - Piper Sandler David Rescott - R.W. Baird Mike Matson - Needham Craig Bijou - Bank of America Securities Jim Sidoti - Sidoti & Company Michael Petusky - Barrington Research Steve Lichtman - Oppenheimer Operator Good day, and thank you for standing by.
Compared to Estimates, Merit Medical (MMSI) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Merit Medical (MMSI) Q3 Earnings and Revenues Surpass Estimates
Merit Medical (MMSI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.75 per share a year ago.
Why Merit Medical (MMSI) is Poised to Beat Earnings Estimates Again
Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Merit Medical Stock Gains 24.7% Year to Date: What's Behind the Rally?
MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.
Here's Why You Should Retain Merit Medical Stock in Your Portfolio
Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
